Vizient has acquired Empierus, a healthcare advisory firm focused on IT contracting, healthcare technology management, and cost optimization, adding a niche capability that targets one of hospitals’ least disciplined spending buckets. Terms were not disclosed.
The move gives Vizient deeper reach into non-labor expense management at a moment when providers are under pressure to fund cybersecurity, cloud migration, AI tools, and broader digital modernization without a matching improvement in margins. IT has become a strategic necessity inside hospitals, but it has also become a procurement blind spot. Contracts are fragmented, vendor oversight is uneven, and many systems still buy software and infrastructure outside the rigor applied to clinical supplies.
Empierus already had a working relationship with Vizient and helped generate more than $36 million in client savings in 2025, according to the company. Folding that team in-house reduces execution risk and turns a partner capability into a proprietary one. That matters for Vizient because the company is building a broader advisory and spend-management platform, not just a group purchasing business. Its 2024 acquisition of Kaufman Hall pointed in the same direction.
Empierus employees will join Vizient’s indirect spend and purchased services unit, where more than 250 specialists work across non-labor categories. Existing client contracts and support models will remain in place.
For hospital executives, the appeal is simple enough. Traditional supply chain savings have become harder to find, while software, telecom, managed services, and medical technology support contracts continue to expand. Vizient wants to sit closer to that budget line and capture more of the advisory economics around it. The company’s scale helps. Vizient says it serves more than two-thirds of the nation’s acute care providers and manages a contract portfolio tied to $156 billion in annual purchasing volume.
The acquisition also lands in a market where buyers are still willing to pay for healthcare assets with clear cost-containment angles. Acquire.fyi data shows health sector deal value has reached $76.8 billion year to date, up 91.8% from a year earlier, even as volume has slipped. That split favors targeted capability buys like Empierus, where the rationale is less about expansion for its own sake and more about owning a tighter grip on provider budgets before rivals do.
Source: Company press release and Acquire.fyi's proprietary data
